Our previous study showed that changes in the expression levels of several ABC genes (ABCB1, ABCC1, ABCC2, ABCC5, ABCG1, and ABCG2) during neoadjuvant chemotherapy (NAC) were associated with the response to this therapy in breast cancer patients [2]. Here, ABCG2 is linked to breast carcinoma.